The disease not only affects the patient, but often caregivers and family members as well. However, most economic analyzes do not consider the spillover effects of disease on caregivers.
…A Latest review of NICE assessments Research shows that only 3% of technology evaluations include caregiver health-related quality of life (HRQoL) in cost-utility analyzes (CUA). Similarly, Ramsar [2022] The study found that 38 (27%) of 139 maternal perinatal CUAs (27%) included maternal and child health outcomes in the analysis, and 20 (3%) of 747 pediatric CUAs % ) takes into account household health spillover effects.This trend of omissions was also observed range etc. [2022] They reported that only 40 of all identified interventions for patients with CUA included quality-adjusted life years (QALYs) for family members.
To address this issue, the Health Economic Spillover Evaluation and Research (SHEER) Working Group was convened to identify good practices for measuring disease spillover effects to caregivers in health economic analyses.As mentioned in Henry et al. (2024)the working group defined these overflows as follows:
… In the context of CEA, family and caregiver health spillovers include the positive and negative effects of an individual's health status on the HRQoL of family members and/or caregivers.
Specific recommendations provided by the SHEER Working Group are listed below.
The paper describes each recommendation in more detail and lists some areas for future research.You can read the full article here.
